FDA-approved Weight Loss Pills - Search News

Novo Nordisk’s Ozempic Gets FDA Approval

Forbes on MSN · 1d

Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug’s Latest Approval

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and strokes.

People on MSN · 4h

FDA Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.

CNBC on MSN · 1d

FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.

1d

Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

3d

Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Hosted on MSN7d

The FDA is about to make weight-loss drugs a lot harder to get

The biggest development in weight-loss medicine since bariatric surgery (not to mention ... to fulfill the needs of ...

7d

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

Compared with Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.

7don MSN

Massive study looks at benefits, risks of GLP-1 weight-loss drugs

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results